Cibisatamab, CAS 1855925-27-7

Product Description: Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Reyes Gonzalez-Exposito, et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. J Immunother Cancer. 2019 Apr 15;7(1):101.

CAS Number: 1855925-27-7

Molecular Weight: N/A

Compound Purity: 91.51

Research Area: Cancer

Solubility: H2O

Target: CD3

• Artikelnummer: MEXHY-P99011-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99011-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK